Targeting AXL cellular networks in kidney fibrosis
We propose that AXL targeting affects an important cellular interaction network underlying fibrotic progression. These results support the clinical application of AXL targeting agents to treat CKD.
Authors
- James B. Lorens (ORCID: https://orcid.org/0000-0002-6782-3349)
- Sturla Magnus Grøndal (ORCID: https://orcid.org/0000-0002-7190-7377)
- Magnus Blø
- Gro Gausdal (ORCID: https://orcid.org/0000-0001-5410-8808)
- Akil Jackson (ORCID: https://orcid.org/0000-0002-4574-544X)
- Austin Rayford
- Linn Iren Hodneland Nilsson
Institutions
- BerGenBio (Norway) (NO)
- University of Bergen (NO)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-04
- DOI
- https://doi.org/10.3389/fimmu.2024.1446672
- Citations
- 5
- Primary Topic
- Phagocytosis and Immune Regulation
- Type
- article
- Field-Weighted Citation Impact
- 1.20
Funders
- Universitetet i Bergen
- Bergens Forskningsstiftelse